Approved and Non Medication Intervention for Children and Adolescents With ADHD Paper

Psychotropic drugs are commonly used for children and adolescents to treat mental health disorders, yet many of these drugs are not FDA approved for use in these populations. Thus, their use is considered “off-label,” and it is often up to the best judgment of the prescribing clinician. As a PMHNP, you will need to apply the best available information and research on pharmacological treatments for children to safely and effectively treat child and adolescent patients. Sometimes this will come in the form of formal studies and approvals for drugs in children. Other times you may need to extrapolate from research or treatment guidelines on drugs in adults. Each individual patient case will need to be considered independently and each treatment considered from a risk assessment standpoint. What psychotherapeutic approach might be indicated as an initial treatment? What are the potential side effects of a particular drug? In 1-2 pages address the following 1. Recommend one FDA -approved drug, one off label drug and one nonpharmacological intervention for treating your assigned disorder (ADHD) in children and adolescents. 2. Explain the risk assessment you would use to inform your treatment decision making. What are the risk and benefits of the FDA-approved medicine ? What are the risks and benefits of the off-label drug? 3. Explain whether clinical practice guidelines exist for the disorder (ADHD) and if so use them to justify your recommendations. 4. Support your reason with three scholarly resources; one on the FDA approved drug, and non-medication intervention for the disorder within 5 years. 5. Attach the pdf version of your sources. APA 7th format using written English. Correct grammar, mechanism and proper punctuation. For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.